H. pylori infection registry study in Shandong
Part of Digestive system, Infections clinical trials.
This study is creating a registry of people with Helicobacter pylori (H. pylori) infection in Shandong Province who choose to have treatment. It will gather information to improve how H. pylori infections are managed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have been diagnosed with H. pylori infection (by a breath test, a rapid test, or a biopsy)
- You are willing to receive standard therapy to get rid of H. pylori
- You do not have severe liver, kidney, or cancer problems
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different first-line antibiotic treatments for H. pylori, a stomach infection that can cause ulcers and other issues. It uses a stool test to choose the best treatment for each person, aiming to improve cure rates and reduce antibiotic resistance.
This study tests a new way to choose antibiotics for H. pylori infection that didn't go away after first treatment. It uses a stool test to look for antibiotic resistance genes, which may help pick a more effective treatment for you.
This study tests a new lab method to check if your H. pylori bacteria are resistant to the antibiotic clarithromycin, which helps doctors choose the best treatment for you. It uses the tissue samples already collected during your endoscopy.
This trial studies whether testing for an infection called H. pylori and using simple blood/screening tests (pepsinogen testing) can help prevent stomach cancer and reduce stomach-cancer-related deaths. You would be followed for health outcomes to see if the approach works better than standard care.
This trial tests a combination of four medications to treat H. pylori, a bacteria that can cause stomach ulcers and other issues. The goal is to see if this newer therapy works well for people who are infected.
This study is a registry that follows adults who have Helicobacter pylori (a common stomach bacteria) to learn how it’s managed in real life. It may help improve care by tracking treatments and outcomes over time.
Hear when a new HELICOBACTER PYLORI INFECTIONS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.